Sign Up for Our E-Newsletter

In The News

Study Shows the Benefit of FIT for People in Their 40s

Posted on April 6, 2016

Research Study

As the number of colorectal cancer diagnoses in people under 50 continues to increase, our community is vigilantly looking at ways to combat this alarming trend. A new study, which looked at the accuracy and efficacy of the fecal occult blood tests (FIT), may be the key to getting this population screened.

Unlike a traditional colonoscopy, which can be expensive, requires dietary restrictions and must be done by a healthcare professional, a FIT can be done right in your own home. Even better, it requires no prep and is fairly inexpensive.

This recent study, “Extending Colorectal Cancer Screening to Persons Aged 40 to 49 Years With Immunochemical Fecal Occult Blood Test: A Prospective Cohort Study of 513,283 Individuals,” followed more than 513,000 individuals who had FIT for 14 years; they found one in seven cases of colorectal cancer in people over 40 occurred in the 40 to 49 age group.

Read more

What is Charity Care?

Posted on March 7, 2016

14445634744_3d2d72c990_o

Medical debt is a growing problem in America. I see it every day in my work as a certified patient navigator and patient advocate here at the Colon Cancer Alliance. Almost 60% of calls to our Helpline have to do with financial need.

As treatments get more specialized and personalized, costs will continue to rise. This financial toxicity is just as dangerous to patients as chemotherapy side effects like neuropathy, rashes, etc. Medical debt is now the leading cause of bankruptcy in America.

One solution to this problem is charity care. Read more

An Important Question to Ask Before Starting 5-FU: Am I DPD Deficient?

Posted on February 9, 2016

fluorouracil-5-fu-group

5-FU (5Fluorouracil) is one of the most common chemotherapies on the market. It is often used to treat cancers of the breast, stomach, pancreas, colon, rectum, head and neck and is given through an IV or infusion. Approved in 1950, it has been the primary treatment for colorectal cancer for more than 60 years.

Read more

CDX2: A Promising New Marker for Stage II & III

Posted on February 9, 2016

pexels-photo

In a study published last month in the New England Journal of Medicine, researchers identified a new marker for recurrence in stage II and stage III colon cancer. We sat down with Dr. Laura Porter to breakdown this new marker, the study, and what this news could mean for you.

Read more

What You Need to Know About Processed Meat, Red Meat and Cancer Risk Pt. 2

Posted on November 13, 2015

Fruit Bowl

In Part 1 of our “What You Need to Know About Processed Meat, Red Meat and Cancer Risk” series, Oncology Dietitian Rhone Levin broke down the International Agency for Research on Cancer and World Health Organization’s (WHO) recent report “Carcinogenicity of consumption of red and processed meat” (which found positive links between consuming red and processed meats and 18 types of cancer) and gave some of examples of processed meats, read meats and protein alternatives.

Now, we’re discussing reducing your cancer risk and ways to incorporate more plant foods.

Read more

css.php